ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $654,489 | -58.5% | 733,568 | 0.0% | 0.51% | -47.9% |
Q2 2023 | $1,577,171 | +10.3% | 733,568 | 0.0% | 0.97% | +6.1% |
Q1 2023 | $1,430,458 | -49.2% | 733,568 | 0.0% | 0.92% | -23.6% |
Q4 2022 | $2,816,901 | -20.3% | 733,568 | 0.0% | 1.20% | -21.7% |
Q3 2022 | $3,536,000 | – | 733,568 | – | 1.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 5,402,041 | $4,845,631 | 1.54% |
Sio Capital Management, LLC | 3,294,534 | $2,955,197 | 0.92% |
Redmile Group, LLC | 14,178,045 | $12,717,706 | 0.60% |
AlphaCentric Advisors LLC | 1,068,468 | $958,416 | 0.54% |
Vantage Consulting Group Inc | 850,737 | $763,111 | 0.51% |
Blue Owl Capital Holdings LP | 733,568 | $654,489 | 0.51% |
Affinity Asset Advisors, LLC | 1,100,000 | $986,700 | 0.28% |
Frazier Life Sciences Management, L.P. | 1,647,030 | $1,477,386 | 0.10% |
Indie Asset Partners, LLC | 92,700 | $83,152 | 0.08% |
GCM Grosvenor Holdings, LLC | 410,888 | $368,567 | 0.07% |